Journals / Eurasian Journal of Pulmonology / 2020 / Cilt: 22 - Sayı: 1

COVID‑19 in children

Pages
82–89
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Inthis review, the frequency of COVID‑19 in children, differences between adults, the course ofpregnancy and newborn, clinical and laboratory findings, and treatment options are reviewed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Coronavirus disease‑2019 (COVID‑19) has affected nearly 2 million people and caused upto 100,000 people death worldwide until today.
📊
Key Findings & Data:It should be kept in mind that COVID-19 may cause severe illness in infants under1 year old and in children with chronic diseases such as chronic kidney disease undergoingdialysis, sickle cell disease, chronic liver disease, endocrine disorders, chronic lung disease,cardiovascular disease, immune deficiency, and severe obesity.
💡
Conclusion & Impact:Inthis review, the frequency of COVID‑19 in children, differences between adults, the course ofpregnancy and newborn, clinical and laboratory findings, and treatment options are reviewed.
🔬Design:Review & Systematic Survey
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Coronavirus disease‑2019 (COVID‑19) has affected nearly 2 million people and caused upto 100,000 people death worldwide until today. This severe disease has seen less in childrenthan adults. This may be due to the fact that cytokine storm in children is milder, viral loadexposure is less than in adults, and angiotensin converting enzyme receptor levels are differentfrom adults. It should be kept in mind that COVID-19 may cause severe illness in infants under1 year old and in children with chronic diseases such as chronic kidney disease undergoingdialysis, sickle cell disease, chronic liver disease, endocrine disorders, chronic lung disease,cardiovascular disease, immune deficiency, and severe obesity. Fever and cough are the mostcommon symptoms in COVID‑19, and children can also be asymptomatic. Laboratory findingsare variable in children. Ground‑glass opacity, consolidation, patchy shadowing, halo sign, andinterstitial anomalies can be detected in lung computed tomography, or it can be normal. Inthis review, the frequency of COVID‑19 in children, differences between adults, the course ofpregnancy and newborn, clinical and laboratory findings, and treatment options are reviewed.

🔖

Cite This Article

ASLAN, A. T., EYÜBOĞLU, T. Ş., ONAY, Z. R. (2022). COVID‑19 in children. Eurasian Journal of Pulmonology, Cilt: 22 - Sayı: 1, 82–89. https://ajindex.com/articles/509593

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Johns Hopkins University Center for Systems Science and Engineering. Coronavirus COVID‑19 Global Cases. Available from: https://gisanddata.maps.arcgis.com/apps/opsdas hboard/index.html#/bda7594740fd 40299423467b48e9ecf6. [Last accessed on 2020 Apr 15]
  2. Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID19) in Zhejiang, China: An observational cohort study. Lancet Infect Dis 2020. pii. S14733099;30198-5
  3. Lee PI, Hu YL, Chen PY, Huang YC, Hsueh PR. Are children less susceptible to COVID19? J Microbiol Immunol Infect 2020. pii: S16841182;30039-6
  4. CDC COVID‑19 Response Team. Coronavirus Disease 2019 in Children ‑ United States, February 12‑April 2, 2020. MMWR Morb Mortal Wkly Rep 2020;69:422‑6
  5. She J, Liu L, Liu W. COVID‑19 epidemic: Disease characteristics in children. J Med Virol 2020; 92:747-4. [doi: 10.1002/jmv. 25807]
  6. Zhang T, CuiX,ZhaoX,Wang J,Zheng J,Zheng G,et al. Detectable SARS‑CoV‑2 viral RNA in feces of three children during recovery period of COVID‑19 pneumonia. J Med Virol 2020;92:909-14. [doi: 10.1002/jmv.25795]
  7. World Health Organization. Report of the WHO‑China Joint Mission on Coronavirus Disease 2019 (COVID19). Geneva: World Health Organization; 2020. Available from: https://www.who.int/docs/default‑source/coronaviruse/ whochina‑joint‑mission‑on‑covid‑19‑final‑report.pdf. [Last accessed on 2020 Apr 14]
  8. Cao Q, Chen YC, Chen CL, Chiu CH. SARS‑CoV‑2 infection in children: Transmission dynamics and clinical characteristics. J Formos Med Assoc 2020;119:670‑3
  9. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID‑19 infection in nine pregnant women: A retrospective review of medical records. Lancet 2020;395:809‑15
  10. Baud D, Giannoni E, Pomar L, Qi X, NielsenSaines K, Musso D, et al. COVID19 in pregnant women Authors’reply. Lancet Infect Dis 2020. pii. S14733099; 30192-4
  11. Liang H, Acharya G. Novel corona virus disease (COVID‑19) in pregnancy:What clinicalrecommendations to follow? Acta Obstet Gynecol Scand 2020;99:439‑42
  12. Favre G, Pomar L, Qi X, Nielsen‑Saines K, Musso D, Baud D. Guidelines for pregnant women with suspected SARS‑CoV‑2 infection. Lancet Infect Dis 2020;20:652-3
  13. Schwartz DA. An analysis of 38 pregnant women with COVID‑19, their newborn infants, and maternal‑fetal transmission of SARS‑CoV‑2: Maternal coronavirus infections and pre